Dublin, June 22, 2023 (GLOBE NEWSWIRE) -- The "Automation in Biopharma Industry Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering.
The Automation in Biopharma market will surpass US$1.85 billion in 2023, this work calculates. The report predicts strong revenue growth through to 2033. this work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
The primary advantage of biopharma automation is that it enhances accuracy and precision. Automated systems can be programmed to perform tasks with increased accuracy and precision, reducing the likelihood of errors and inconsistencies that may affect drug quality. Biopharma automation can also reduce the risk of contamination by reducing the need for human intervention, thereby improving product purity.
Another significant benefit of biopharma automation is improved efficiency. Automated systems can operate continuously and perform repetitive tasks much more quickly than humans, reducing manufacturing time and increasing productivity. This can result in significant cost savings and faster drug production.
Biopharma automation also provides enhanced process control. Automated systems can monitor and control manufacturing processes more closely, ensuring that critical process parameters are maintained within a narrow range. This can result in consistent product quality and a reduced risk of batch failures.
Overall, biopharma automation has numerous benefits in terms of increased efficiency, reduced risk of errors and contamination, and improved product quality and consistency, making it an essential tool in the biopharmaceutical industry.
Market Dynamics
- Drivers
- Labour Shortages Comprising Both High- and Low-Skilled Workers Were a Problem for Manufacturers Before the Pandemic
- Need for Increased Machine Flexibility
- Technological Advancements to Improve Product Safety
- Automation Drives Efficiencies
- Restraints
- Need for High Capital Investment Limits the Market Expansion
- Stringent Regulatory Norms to Challenge Market Growth
- Smaller Datasets
- Opportunities
- Working Smarter Using Digital Labour
- Robotics are Increasingly Regarded as Valuable to Operations
- Faster Hypothesis to Testing Cycles
Key Questions Answered in the Report
- How is the automation in biopharma industry market evolving?
- What is driving and restraining the automation in biopharma industry market?
- How will each automation in biopharma industry submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
- How will the market shares for each automation in biopharma industry submarket develop from 2023 to 2033?
- What will be the main driver for the overall market from 2023 to 2033?
- Will leading automation in biopharma industry markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
- Who are the leading players and what are their prospects over the forecast period?
- What are the automation in biopharma industry projects for these leading companies?
- How will the industry evolve during the period between 2023 and 2033? What are the implications of automation in biopharma industry projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the automation in biopharma industry market?
- Where is the automation in biopharma industry market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
Companies Profiled
- PerkinElmer, Inc.
- Siemens Healthineers
- ABB Robotics
- Rockwell Automation, Inc.
- Thermo Fisher Scientific Inc.
- Sartorius Stedim Biotech SA
- RheoSense Inc.
- Emerson Electric Co.
- TetraScience, Inc.
- ADLINK Technology Inc.
- Acieta LLC
- AMETEK
- Autodesk, Inc.
- Baumueller-Nuermont Corp.
- Kawasaki Robotics
In summary, this 390+ page report provides you with the following knowledge:
- Revenue forecasts to 2033 for Automation in Biopharma Industry Market, 2023 to 2033 Market, with forecasts for technology, application, component, automation technology, digitisation technology, and company size, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2033 for five regional and 20 key national markets - See forecasts for the Automation in Biopharma Industry Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market - including company profiles for 15 of the major companies involved in the Automation in Biopharma Industry Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. The study is for everybody needing commercial analyses for the Automation in Biopharma Industry Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
For more information about this report visit https://www.researchandmarkets.com/r/r0rkvf
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
